1. Gastric cancer: Metabolic and metabolomics perspectives (Review).
   Shiyu Xiao et al, 2017, Int J Oncol CrossRef
2. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner
   Zhang-Feng Zhong et al, 2016, Mol. BioSyst. CrossRef
3. Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression
   Andréia Vasconcelos-dos-Santos et al, 2018, J Bioenerg Biomembr CrossRef
4. Population-based cohort study of diabetes mellitus and mortality in gastric adenocarcinoma
   J. Zheng et al, 2018, Br J Surg CrossRef
5. Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells
   Loredana Bergandi et al, 2018, Front. Pharmacol. CrossRef
6. NAD Metabolism in Cancer Therapeutics
   Keisuke Yaku et al, 2018, Front. Oncol. CrossRef
7. AQP9-induced cell cycle arrest is associated with RAS activation and improves chemotherapy treatment efficacy in colorectal cancer
   Dandan Huang et al, 2017, Cell Death Dis CrossRef
8. Effects of hyperglycemia on the progression of tumor diseases
   Wenjie Li et al, 2019, J Exp Clin Cancer Res CrossRef
9. Role of microRNAs in drug resistance of gastric cancer cells
   Bi-Bo Tan et al, 2019, WCJD CrossRef
10. MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells
    Chunying Li et al, 2016, Med Sci Monit CrossRef
11. Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality
    null Ramteke et al, 2019, Cancers CrossRef
12. Hyperglycemia promotes Snail-induced epithelial–mesenchymal transition of gastric cancer via activating ENO1 expression
    Xin Xu et al, 2019, Cancer Cell Int CrossRef
13. Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4
    Surbhi Chouhan et al, 2020, J Biosci CrossRef
14. Metronomic chemotherapy remodel cancer‑associated fibroblasts to decrease chemoresistance of gastric cancer in nude mice
    Chao Wang et al, 2017, Oncol Lett CrossRef
15. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer.
    Zhuo Zeng et al, 2020, PeerJ CrossRef
16. NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP
    Antonio Lucena-Cacace et al, 2018, Clin Cancer Res CrossRef
17. High glucose: an emerging association between diabetes mellitus and cancer progression
    Suangson Supabphol et al, 2021, J Mol Med CrossRef
18. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
    Chin-Hsiao Tseng, 2021, Biomolecules CrossRef
19. Fatty acid synthase mediates high glucose‐induced EGFR activation in oral dysplastic keratinocytes
    David J. Wisniewski et al, 2021, J Oral Pathol Med CrossRef
20. Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells
    Vivek Kumar Soni et al, 2021, Front. Oncol. CrossRef
21. Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
    Tsung-Chieh Lin, 2022, Cancers CrossRef
22. Cellular and molecular insights into the roles of visfatin in breast cancer cells plasticity programs.
    Pradeep Kumar Rajput et al, 2022, Life Sci CrossRef
23. Alterations in the gastric microbiota and metabolites in gastric cancer: An update review
    Changzhen Lei et al, 2022, Front. Oncol. CrossRef
24. Gastric adenocarcinoma: 1-year overall survival, disability-adjusted life years, years of life lost, and prognostic factors—a single-institution experience
    Tatiane Tiengo et al, 2022, Front. Oncol. CrossRef
25. Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection
    Sananda Dey et al, 2022, Biomedicine & Pharmacotherapy CrossRef
26. Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: mechanistic insights and biomaterial platforms
    Delaram Shakiba et al, 2023, Advanced Drug Delivery Reviews CrossRef
27. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer
    Zekeriya Hannarici et al, 2023, Future Oncology CrossRef
28. Relationship between anticancer sensitivities and cellular respiration properties in 5‐fluorouracil‐resistant HCT116 human colorectal cancer cells
    Chinatsu Kurasaka et al, 2023, FEBS Open Bio CrossRef
29. Assessing the Link between Diabetic Metabolic Dysregulation and Breast Cancer Progression
    Samrein B. M. Ahmed et al, 2023, IJMS CrossRef
30. Ketosis Suppression and Ageing (KetoSAge): The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females
    Isabella D. Cooper et al, 2023, IJMS CrossRef
31. Anticancer sensitivity and biological aspect of 5-fluorouracil-resistant human colorectal cancer HCT116 cells in three-dimensional culture under high- and low-glucose conditions
    Chinatsu Kurasaka et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef
32. Metabolic Factors Associated with Endoscopic Atrophy, Intestinal Metaplasia, and Gastric Neoplasms in Helicobacter pylori-Positive Patients
    Junya Arai et al, 2024, Clinics and Practice CrossRef
33. Critical Role of Preoperative Hyperglycemia in Association with GFAT-1 Expression in Resected Pancreatic Cancer
    Yuichiro Kohara et al, 2024, Ann Surg Oncol CrossRef
34. “Hyperglycemic Memory”: Observational Evidence to Experimental Inference
    Mohsen Ahmadi et al, 2025, CDR CrossRef